1-12 of 12
Fengyan Jin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

When Patients with Plasma Cell Disorders Encountered the Largest Omicron Wave (December 2022) in China: A Real-World Multicenter and Multiregional Study

Xincheng Jiang, Zhen Cai, Xiaoyan Han, Fengyan Jin, Gang An, Jian Hou, Jingsong He, Qingming Wang, Wenjun Wu, Yi Zhao, Songfu Jiang, Shuchan Li, Zhenshu Xu, Gaofeng Zheng, Yang Yang, Qingxiao Chen, Donghua He, Yi Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6673.
https://doi.org/10.1182/blood-2023-174224
Published: 2023
Journal Articles

TET2 Down-Regulation Confers Bortezomib Resistance in Multiple Myeloma

Yun Dai, Xiaobo Liu, Ting Yang, Shaji K Kumar, Fengyan Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 4185–4186.
https://doi.org/10.1182/blood-2022-168239
Published: 2022
Journal Articles

A Simple Risk-Scoring Model for Estimating the Prognostic Impact of 1q Gain in Patients with Newly-Diagnosed Multiple Myeloma

Fengyan Jin, Peiyu Yang, Haimin Chen, Xinyue Liang, Weiling Xu, Shanshan Yu, Wenyang Huang, Xingchen Yi, Qiang Guo, Mengru Tian, Tingting Yue, Mengyao Li, Yingjie Zhang, Mengxue Zhang, Yurong Yan, Zhongli Hu, Shaji K Kumar, Fan Zhou, Yun Dai
Journal: Blood
Blood (2022) 140 (Supplement 1): 4360–4361.
https://doi.org/10.1182/blood-2022-168602
Published: 2022
Journal Articles

IRF4 Is Reciprocally Dysregulated Via NF-Κb-Dependent Expression and Loss-of-Function Mutations in Multiple Myeloma

Yun Dai, MD, Yue Sun, MS, Shaji K. Kumar, MD, Wei Wu, MD, Fengyan Jin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 687.
https://doi.org/10.1182/blood-2019-132051
Published: 2019
Journal Articles

Comprehensive Geriatric Assessment in Consecutive Newly-Diagnosed Elderly Multiple Myeloma Patients in China: A Multicentered, Prospective, Non-Interventional Study

Yuan Yao, Dehui Zou, Aijun Liao, Xiaoxia Chu, Wei Wang, Xinan Cen, Lijuan Chen, MD PhD, Li Bao, Rong Fu, Jr., PhD, Hui Liu, Chunyan Sun, MD PhD, Luqun Wang, MD, Fengyan Jin, MD PhD, Hua Yan, Chenglu Yuan, Liangming Ma, Guangxun Gao, Jinqiao Zhang, MD, Da Gao, MD, Jianda Hu, PhD, Jianxia He, Ai-lin Zhao, Lu Zhang, MD, Dao-Bin Zhou, Jian Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5493.
https://doi.org/10.1182/blood-2019-125447
Published: 2019
Journal Articles

A Multi-Center Epidemiological and Prognostic Analysis of Cytogenetic Abnormalities in a Cohort of 1015 Chinese Patients with Newly-Diagnosed Multiple Myeloma

Fengyan Jin, MD PhD, Guangxun Gao, MD, Yujun Dong, MD, Chunrui Li, MD PhD, Wenrong Huang, Limo Zhang, MD, Qiang Zhu, MD, Ruifeng Yuan, MD, Li Xu, MD, Yanjie Xu, MD, Qian Xu, Shaji K. Kumar, MD, Yun Dai, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3094.
https://doi.org/10.1182/blood-2019-132076
Published: 2019
Journal Articles

The Lysine-Specific Demethylase KDM4A/JMJD2A Acts As a Tumor Suppressor in Multiple Myeloma

Fengyan Jin, MDPhD, Shaji K. Kumar, MD, Yun Dai, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 191.
https://doi.org/10.1182/blood-2018-191
Published: 2018
Journal Articles

Suppression of Cdc37 Induces BTZ Resistance through XBP1s Mediated Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Lanting LIU, Fengyan Jin, Jiaojiao Guo, An Gang, MD, Xiaoqi Qin, Tao Zhu, Shuhui Deng, Zhang Shuaishuai, MD, Mu Hao, PhD, Xiaoyan Feng, Yan Xu, MD, Wen Zhou, Lugui Qiu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4350.
https://doi.org/10.1182/blood.V130.Suppl_1.4350.4350
Published: 2017
Journal Articles

Clarithromycin Interacts with Lenalidomide in the Combination Regimen Bird and Overcomes Drug Resistance in Multiple Myeloma

Fengyan Jin, MD PhD, Shuang Li, MD, Lijuan Chen, PhD, Chuan Wu, MD, Wei Li, MD, Jian Hou, MD, Yun Dai, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2125.
https://doi.org/10.1182/blood.V128.22.2125.2125
Published: 2016
Journal Articles

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Fengyan Jin, Lanting Liu, Gang An, MDPhD, Xiaoqi Qin, MD, Xiaoyan Feng, Yan Xu, MDPhD, Mu Hao, MD PhD, Wen Zhou, PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2480.
https://doi.org/10.1182/blood.V126.23.2480.2480
Published: 2015
Journal Articles

Antitumor Activity of a Novel Proteasome Inhibitor BSc2118 Against Multiple Myeloma

Meirong Zang, PhD, Lanting Liu, Xin Li, Wei Li, MD, Ulrike Kuckelkorn, Wen Zhou, PhD, Lugui Qiu, MD, Fengyan Jin, MD
Journal: Blood
Blood (2014) 124 (21): 5725.
https://doi.org/10.1182/blood.V124.21.5725.5725
Published: 2014
Journal Articles

Abnormalities Of FAM46C, AHCYL1, CDC14A and CDKN2C Genes Located At Chromosome 1p Detected By QM-FISH Identifies Deletion Of 1p32.3 Covered CDKN2C Is An Independent Adverse Prognostic Marker In Multiple Myeloma

Fei Li, Li-ping Hu, FengYan Jin, Yan Xu, MD., Gang An, Zengjun Li, Mei-rong Zang, Shu-hui Deng, Dehui Zou, Hong Chang, Lugui Qiu, MD
Journal: Blood
Blood (2013) 122 (21): 3145.
https://doi.org/10.1182/blood.V122.21.3145.3145
Published: 2013